Drug firm Pfizer on Wednesday, in an exchange filing, announced that its Managing Director S Sridhar has resigned from the company. According to the filing, Sridhar has expressed his intention to retire early.

Share Market Live

NSE

The company stated that Sridhar would continue to serve as the MD until the identification, selection and transition to the new leadership takes place. The effective date of his resignation will be announced later after discussions between Sridhar and Pfizer's board of directors.

Also Read: Teaser: New MG Hector facelift sports diamond mesh grille — Check pictures

Sridhar has been associated with Pfizer for the last 14 years and has held various key leadership positions. He also served as the Chief Financial Officer for eight years. Sridhar held the position of MD for six years.

"Sridhar made significant contributions to the growth of the xompany’s portfolio, presence across India and reach to patients who have benefited from access to Pfizer therapies," the company said.

Also Read: This chemical additives stock zooms 15% as profit jumps four times

Sridhar has also served as the co-chair of the FICCI Pharmaceuticals

Committee and is the current President of the Organization of

Pharmaceuticals Producers of India (OPPI).

First Published:Aug 10, 2022 1:49 PM IST